An Overprotective FDA?
Patients’ Right to Choose, a Washington Times commentary, argues that the FDA (and drug manufacturers) overreacts to safety concerns of drugs at the expense of treating patients who need the medications. Fundamentally, the ability for patients to consult with doctors and make informed treatment decisions…